Personalized 3D printing transforms
reconstructive operations and significantly reduces surgery
time
Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”), a
leader in polymer 3D printing solutions, has shared that the
University Hospital Birmingham in England is delivering improved
outcomes for head and neck cancer patients, with the hospital
reporting reduced surgery times of up to three hours through the
use of tailored, 3D printed cutting guides.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231213529898/en/
University Hospital Birmingham is
improving patient outcomes and reducing surgery times with the
integration of tailored, 3D printed surgical guides. (Photo:
Business Wire)
This success is attributed to the integration of a Stratasys J5
MediJet™ 3D printer that enables the hospital to create highly
accurate, patient-specific cutting guides ahead of operations,
transforming the way tumors are removed from head and neck cancer
patients. Previously, these would have been created by cutting and
bending a piece of metal by hand while the patient was on the
operating table, resulting in a time-consuming process with a large
margin for error.
Using 3D printing, the surgical team can now produce highly
accurate devices using patient scans, with a resolution of within
150 microns, helping to support surgical outcomes. These are
produced in Biocompatible Clear MED610™; a rigid, transparent resin
suitable for applications requiring long-term contact (more than 30
days) with intact skin and limited contact (up to 24 hours) with
tissue, bone or mucosal membranes.
“In addition to saving up to three hours of surgery time, 3D
printing also enables much better surgical planning,” says Stefan
Edmondson, Consultant Clinical Scientist (Reconstructive Science)
at the hospital. “Using patient scans, the team is able to create
3D visualizations based on the distinct anatomy of each patient –
and then leverage 3D printing technology to produce both anatomical
models and personalized surgical cutting guides ahead of the actual
operation.
“This capability means we can not only accurately predict the
surgery before it’s done, but that we have the tools to ensure that
the meticulous pre-surgical planning can be executed with the
utmost precision,” explains Edmondson. “The surgical team is also
much better prepared and the patient is far more at ease, as we can
talk through the process and expected outcomes prior to going into
the operating theater,” he adds.
According to the hospital, taking a segment of a patient’s
fibula and molding it into the exact shape and size to transplant
into the target area within the head or neck, while ensuring bone
tissue is kept alive, is a highly complex process in which 3D
printing really demonstrates superior capabilities over
conventional methods.
“In this scenario, if the angles you’re cutting at aren’t
absolutely perfect, the bone won’t fit and there will be a higher
tendency for the body to reject it, leading to significant
discomfort for the patient,” continues Edmondson. “Thankfully, the
3D printed cutting guides are accurate to micron level, ensuring
the fibula is cut to the best possible fit for our patients.”
Stratasys’ GrabCAD Print Software that works alongside this
printer, has also proven to deliver additional benefits. Its
ability to automatically build support material contributes to the
overall end-to-end timesaving facilitated by the 3D printing
workflow.
A pioneer in using additive manufacturing for medical
applications, University Hospital Birmingham has long-standing
experience with various Stratasys 3D printers and technologies. The
hospital’s multi-material, full color printer was acquired through
Stratasys’ UK based reseller, Tri-Tech 3D. “Stratasys is the gold
standard of 3D printers – something that is exemplified in the J5
MediJet,” adds Edmondson. “Beyond its ability to produce highly
accurate cutting guides and brilliantly vivid anatomic models that
are biocompatible and sterilizable, it is really easy to use, which
makes it a winner with our team.”
Launched in 2021, the J5 MediJet™ gives users the ability to
create multi-material, full color prints in a single tray. Hosted
in a single office-friendly platform, which reduces outsourcing
costs or the need for multiple printers, the system is built to
maximize reliability and simplify maintenance.
About Stratasys
Stratasys is leading the global shift to additive manufacturing
with innovative 3D printing solutions for industries such as
aerospace, automotive, consumer products, healthcare, fashion and
education. Through smart and connected 3D printers, polymer
materials, a software ecosystem, and parts on demand, Stratasys
solutions deliver competitive advantages at every stage in the
product value chain. The world’s leading organizations turn to
Stratasys to transform product design, bring agility to
manufacturing and supply chains, and improve patient care. To learn
more about Stratasys, visit www.stratasys.com, the Stratasys blog,
Twitter/X, LinkedIn, or Facebook.
Stratasys reserves the right to utilize any of the foregoing
social media platforms, including Stratasys’ websites, to share
material, non-public information pursuant to the SEC’s Regulation
FD. To the extent necessary and mandated by applicable law,
Stratasys will also include such information in its public
disclosure filings.
Stratasys, J5 MediJet™ are trademarks or registered trademarks
of Stratasys Ltd. and/or its affiliates. All other trademarks are
the property of their respective owners, and Stratasys assumes no
responsibility with regard to the selection, performance, or use of
these non-Stratasys products.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231213529898/en/
Investor and Media
Contacts:
Stratasys Corporate & North America Chris
Reese chris.reese@stratasys.com +1 651 357 0877 Investor
Relations Yonah Lloyd yonah.lloyd@stratasys.com +972 74 745
4919 Europe, Middle East, & Africa Jonathan Wake /
Samantha White, Incus Media stratasys@incus-media.com +44 1737
215200 Brazil, Central America and South America Erica
Massini erica.massini@stratasys.com +55 (11) 2626 9229
Israel Rosa Coblens rosa.coblens@stratasys.com +852 9189
7273
Stratasys (NASDAQ:SSYS)
過去 株価チャート
から 12 2024 まで 1 2025
Stratasys (NASDAQ:SSYS)
過去 株価チャート
から 1 2024 まで 1 2025
